Keywords: |
immunohistochemistry; cancer chemotherapy; aged; unclassified drug; review; case report; sorafenib; drug safety; side effect; skin toxicity; carcinoma, hepatocellular; liver neoplasms; cancer radiotherapy; pancreas cancer; pancreatic neoplasms; adenocarcinoma; quality of life; computer assisted tomography; image analysis; tomography, x-ray computed; patient assessment; monoclonal antibody; abdominal pain; skin exfoliation; membrane protein; cancer size; cytokeratin 20; blood pressure; intestine perforation; cytokeratin 7; liver biopsy; heart muscle ischemia; skin bleeding; skin ulcer; thyroid transcription factor 1; cytokeratin 18; skin pain; evaluation studies as topic; gross cystic disease fluid protein 15; hepar 1 protein; monoclonal antibody 31; upper abdominal pain
|